Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive · Last trade price on Oct 27, 2025

Tourmaline Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,23852053242626-
Market Cap Growth
75.11%-2.42%1153.91%-93.21%--
Enterprise Value
998.75261.47329.961.83381.5936.66
Last Close Price
47.9820.2826.1810.20152.90-
PE Ratio
--7.02-2.95-0.45-9.320
PB Ratio
4.761.732.60-2.152.580
P/TBV Ratio
4.771.710.61-0.451.83-
P/FCF Ratio
--6.72-18.92-6.51-14.750
P/OCF Ratio
--6.72-18.96-6.58-15.640
EV/EBITDA Ratio
--2.92-7.27-3.14-8.14-1.65
EV/EBIT Ratio
--2.91-7.27-3.14-8.03-1.62
EV/FCF Ratio
--3.38-11.72-9.47-8.99-1.79
Debt / Equity Ratio
0.000.000.00-0.0300
Debt / EBITDA Ratio
0.000.00-0.01-0.03--
Debt / FCF Ratio
0.000.00-0.01-0.08--
Quick Ratio
23.7028.9940.576.0630.5543.92
Current Ratio
24.6830.1841.766.1030.8644.29
Return on Equity (ROE)
-31.64%-28.99%-45.46%-17.66%-46.74%59.52%
Return on Assets (ROA)
-35.43%-34.56%-41.40%-15.12%-23.51%-14.85%
Return on Invested Capital (ROIC)
-328.60%-402.58%-2586.67%-672.85%-1370.06%-1119.09%
Return on Capital Employed (ROCE)
-36.64%-35.51%-42.63%-15.69%-24.19%-15.19%
Earnings Yield
-7.15%-14.25%-33.88%-220.20%-10.73%-
FCF Yield
-6.97%-14.87%-5.28%-15.37%-6.78%-
Buyback Yield / Dilution
--31.06%-0.03%0.00%-22.39%-
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q